
IMVARIA Presents Multi-Site Clinical Data on FDA-Approved AI Tool for Pulmonary Fibrosis at ATS 2025
IMVARIA Showcases Real-World Success of FDA-Authorized AI Tool Fibresolve for Lung Disease Diagnosis at ATS 2025 IMVARIA Inc., a trailblazing health tech company specializing in AI-driven digital biomarker solutions, is making waves in the medical community with its groundbreaking diagnostic…











